Am J Health-Syst Pharm
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Order Full text via Infotrieve
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nadzam, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nadzam, D.
American Journal of Hospital Pharmacy, Vol 48, Issue 9, 1925-1930
Copyright © 1991 by American Society of Health-System Pharmacists

Articles

Development of medication-use indicators by the Joint Commission on Accreditation of Healthcare Organizations

DM Nadzam


The development of indicators for monitoring medication use is described. The Joint Commission on Accreditation of Healthcare Organizations is establishing a national database for use in measuring performance. Initially, indicators were developed for specialties or clinical departments and for disease entities or procedures; now, indicators for key functions that cross departmental and specialty lines, such as medication use, are under development. An interdisciplinary core group constructed a medication-use flow chart depicting prescribing, dispensing, administering, and monitoring patient response; systems management/control was recognized as a fifth component. Sixteen processes were identified for which indicators were developed. Proposed indicators are now being tested in a small number of hospitals. The indicator data will enable institutions to identify areas for improvement. Although the Joint Commission will not use indicator rates per se to determine accreditation, it will ask an institution to provide an interpretation of indicator data that differ markedly from previous data or data for comparable institutions and to review its strategy for analyzing the rates. Use of indicator data will enhance the accreditation process by allowing for ongoing monitoring of particular aspects of performance between onsite surveys.
 



This article has been cited by other articles:


Home page
 PediatricsHome page
G. Suresh, J. D. Horbar, P. Plsek, J. Gray, W. H. Edwards, P. H. Shiono, R. Ursprung, J. Nickerson, J. F. Lucey, D. Goldmann, et al.
Voluntary Anonymous Reporting of Medical Errors for Neonatal Intensive Care
Pediatrics, June 1, 2004; 113(6): 1609 - 1618.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Med. Inform. Assoc.Home page
D. S. Bell, S. Cretin, R. S. Marken, and A. B. Landman
A Conceptual Framework for Evaluating Outpatient Electronic Prescribing Systems Based on Their Functional Capabilities
J. Am. Med. Inform. Assoc., January 1, 2004; 11(1): 60 - 70.
[Abstract] [Full Text] [PDF]

Home page
 J Oncol Pharm PractHome page
R. J. Ignoffo and R. King
Pharmaceutical care and the cancer patient
Journal of Oncology Pharmacy Practice, December 1, 1995; 1(4): 7 - 19.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by the American Society of Health-System Pharmacists.